Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Tema
Tratamiento no farmacológico
364 ARTíCULOS , VIENDO DEL 286 AL 300
Cunningham EL, Passmore AP.
Maturitas. 2013 Nov;76(3):260-6. doi: 10.1016/j.maturitas.2013.04.013. Epub 2013 May 23.
0
0
0
Antidepressants for neuro-regeneration: from depression to Alzheimer's disease
Kim HJ, Kim W, Kong SY.
Arch Pharm Res. 2013 Nov;36(11):1279-90. doi: 10.1007/s12272-013-0238-8. Epub 2013 Oct 16.
0
0
0
A phase 3 trial of semagacestat for treatment of Alzheimer's disease
Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG, Aisen PS; Alzheimer's Disease Cooperative Study Steering Committee; Siemers E, Sethuraman G, Mohs R; Sem
N Engl J Med. 2013 Jul 25;369(4):341-50. doi: 10.1056/NEJMoa1210951.
0
0
0
[Psychosocial interventions in dementia]
Kurz A.
Nervenarzt. 2013 Jan;84(1):93-103; quiz 104-5. doi: 10.1007/s00115-012-3655-x.
0
0
0
Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer's disease
Romero A, Cacabelos R, Oset-Gasque MJ, Samadi A, Marco-Contelles J.
Bioorg Med Chem Lett. 2013 Apr 1;23(7):1916-22. doi: 10.1016/j.bmcl.2013.02.017. Epub 2013 Feb 16.
0
0
0
A review on cholinesterase inhibitors for Alzheimer's disease
Anand P, Singh B.
Arch Pharm Res. 2013 Apr;36(4):375-99. doi: 10.1007/s12272-013-0036-3. Epub 2013 Feb 24.
0
0
0
Alzheimer's disease drug development: translational neuroscience strategies
Cummings JL, Banks SJ, Gary RK, Kinney JW, Lombardo JM, Walsh RR, Zhong K.
CNS Spectr. 2013 Jun;18(3):128-38. doi: 10.1017/S1092852913000023. Epub 2013 Mar 11.
0
0
0
Cell and gene therapy in Alzheimer's disease
Glat MJ, Offen D.
Stem Cells Dev. 2013 May 15;22(10):1490-6. doi: 10.1089/scd.2012.0633. Epub 2013 Mar 4.
0
0
0
[Pharmacological and non-pharmacological treatment of Alzheimer's dementia]
Wallesch CW.
MMW Fortschr Med. 2013 May 2;155(8):60-2. doi: 10.1007/s15006-013-0643-4.
0
0
0
Rivastigmine patch and massage for Alzheimer's disease patients
Satoh S, Kajiwara M, Kiyokawa E, Toukairin Y, Fujii M, Sasaki H.
Geriatr Gerontol Int. 2013 Apr;13(2):515-6. doi: 10.1111/ggi.12010.
0
0
0
Alves J, Magalhães R, Thomas RE, Gonçalves OF, Petrosyan A, Sampaio A.
Alzheimer Dis Assoc Disord. 2013 Jul-Sep;27(3):195-203. doi: 10.1097/WAD.0b013e31827bda55.
0
0
0
Neuroprotective properties of curcumin in Alzheimer's disease--merits and limitations
Chin D, Huebbe P, Pallauf K, Rimbach G.
Curr Med Chem. 2013;20(32):3955-85. doi: 10.2174/09298673113209990210.
0
0
0
A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease
Peters KR, Lynn Beattie B, Feldman HH, Illes J.
Prog Neurobiol. 2013 Nov;110:114-23. doi: 10.1016/j.pneurobio.2012.12.001. Epub 2013 Jan 21.
0
0
0
Amiri H, Saeidi K, Borhani P, Manafirad A, Ghavami M, Zerbi V.
ACS Chem Neurosci. 2013 Nov 20;4(11):1417-29. doi: 10.1021/cn4001582. Epub 2013 Sep 26.
0
0
0
New treatment strategies for Alzheimer's disease: is there a hope?
Aprahamian I, Stella F, Forlenza OV.
Indian J Med Res. 2013 Oct;138(4):449-60.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
